人类端粒酶逆转录酶作为不同癌症类型的主要治疗靶点

Z. Singh, Priya Khangotra
{"title":"人类端粒酶逆转录酶作为不同癌症类型的主要治疗靶点","authors":"Z. Singh, Priya Khangotra","doi":"10.15761/TIM.1000177","DOIUrl":null,"url":null,"abstract":"Telomerase is a known global therapeutic target in cancer cells. Human telomerase reverse transcriptase (hTERT) is a catalytic subunit of the telomerase enzyme. hTERT is usually silenced in almost all somatic cells but it is significantly expressed in ~90 % of human cancers. Many cancer suppressing genes produce factors that hinder hTERT activity. Here, in this review paper, an attempt has been made to emphasize the role of hTERT in different cancer types. Various recent therapeutic studies involving hTERT suppression have also been discussed. Serum hTERT mRNA levels have been found to reflect the tumour burden and the clinical status of the patient. Nano-formulations like nano-curcumin and nano-chrysin have also been shown to significantly decrease hTERT gene expression in SW480 cells. High frequency of hTERT-promoting mutations and increased expression of hTERT mRNA makes it a suitable target in different cancer types. *Correspondence to: Zorawar Singh, Assistant Professor, Department of Zoology, Khalsa College Amritsar, Punjab, India, Tel: +91-94172-30075; E-mail: zorawarsinghs@rediffmail.com","PeriodicalId":23337,"journal":{"name":"Trends in Medicine","volume":"20 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Human telomerase reverse transcriptase as a major therapeutic target in different cancer types\",\"authors\":\"Z. Singh, Priya Khangotra\",\"doi\":\"10.15761/TIM.1000177\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Telomerase is a known global therapeutic target in cancer cells. Human telomerase reverse transcriptase (hTERT) is a catalytic subunit of the telomerase enzyme. hTERT is usually silenced in almost all somatic cells but it is significantly expressed in ~90 % of human cancers. Many cancer suppressing genes produce factors that hinder hTERT activity. Here, in this review paper, an attempt has been made to emphasize the role of hTERT in different cancer types. Various recent therapeutic studies involving hTERT suppression have also been discussed. Serum hTERT mRNA levels have been found to reflect the tumour burden and the clinical status of the patient. Nano-formulations like nano-curcumin and nano-chrysin have also been shown to significantly decrease hTERT gene expression in SW480 cells. High frequency of hTERT-promoting mutations and increased expression of hTERT mRNA makes it a suitable target in different cancer types. *Correspondence to: Zorawar Singh, Assistant Professor, Department of Zoology, Khalsa College Amritsar, Punjab, India, Tel: +91-94172-30075; E-mail: zorawarsinghs@rediffmail.com\",\"PeriodicalId\":23337,\"journal\":{\"name\":\"Trends in Medicine\",\"volume\":\"20 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends in Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15761/TIM.1000177\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/TIM.1000177","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

端粒酶是癌症细胞中已知的全球性治疗靶点。人类端粒酶逆转录酶(hTERT)是端粒酶的催化亚基。hTERT通常在几乎所有体细胞中沉默,但在约90%的人类癌症中显著表达。许多癌症抑制基因产生阻碍hTERT活性的因子。在这篇综述中,我们试图强调hTERT在不同癌症类型中的作用。最近各种涉及hTERT抑制的治疗研究也进行了讨论。已发现血清hTERT mRNA水平反映肿瘤负荷和患者的临床状态。纳米姜黄素和纳米黄素等纳米制剂也被证明可以显著降低SW480细胞中的hTERT基因表达。hTERT促进突变的高频率和hTERT mRNA表达的增加使其成为不同癌症类型的合适靶点。*通讯:印度旁遮普省阿姆利则卡尔萨学院动物学系助理教授Zorawar Singh,电话:+91-94172-30075;电子邮件:zorawarsinghs@rediffmail.com
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Human telomerase reverse transcriptase as a major therapeutic target in different cancer types
Telomerase is a known global therapeutic target in cancer cells. Human telomerase reverse transcriptase (hTERT) is a catalytic subunit of the telomerase enzyme. hTERT is usually silenced in almost all somatic cells but it is significantly expressed in ~90 % of human cancers. Many cancer suppressing genes produce factors that hinder hTERT activity. Here, in this review paper, an attempt has been made to emphasize the role of hTERT in different cancer types. Various recent therapeutic studies involving hTERT suppression have also been discussed. Serum hTERT mRNA levels have been found to reflect the tumour burden and the clinical status of the patient. Nano-formulations like nano-curcumin and nano-chrysin have also been shown to significantly decrease hTERT gene expression in SW480 cells. High frequency of hTERT-promoting mutations and increased expression of hTERT mRNA makes it a suitable target in different cancer types. *Correspondence to: Zorawar Singh, Assistant Professor, Department of Zoology, Khalsa College Amritsar, Punjab, India, Tel: +91-94172-30075; E-mail: zorawarsinghs@rediffmail.com
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信